Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

CAS 915095-86-2 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 915095-86-2
Also known as: 915095-86-2, (2-chloro-5-iodophenyl)-(4-fluorophenyl)methanone, (2-chloro-5-iodo-phenyl)-(4-fluoro-phenyl)-methanone, Methanone, (2-chloro-5-iodophenyl)(4-fluorophenyl)-, (2-chlor-5-iod-phenyl)-(4-fluoro-phenyl)-methanone, Ec 619-596-4
Molecular Formula
C13H7ClFIO
Molecular Weight
360.55  g/mol
InChI Key
KNYGUQLVFSPVRI-UHFFFAOYSA-N

1 2D Structure

CAS 915095-86-2

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2-chloro-5-iodophenyl)-(4-fluorophenyl)methanone
2.1.2 InChI
InChI=1S/C13H7ClFIO/c14-12-6-5-10(16)7-11(12)13(17)8-1-3-9(15)4-2-8/h1-7H
2.1.3 InChI Key
KNYGUQLVFSPVRI-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1C(=O)C2=C(C=CC(=C2)I)Cl)F
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 915095-86-2

2. (2-chloro-5-iodophenyl)-(4-fluorophenyl)methanone

3. (2-chloro-5-iodo-phenyl)-(4-fluoro-phenyl)-methanone

4. Methanone, (2-chloro-5-iodophenyl)(4-fluorophenyl)-

5. (2-chlor-5-iod-phenyl)-(4-fluoro-phenyl)-methanone

6. Ec 619-596-4

7. Schembl2638961

8. Dtxsid301045098

9. Bcp12333

10. Mfcd22665920

11. Zinc34775738

12. Akos024464565

13. Ds-7777

14. Cs-0006692

15. A860348

2.3 Create Date
2007-02-21
3 Chemical and Physical Properties
Molecular Weight 360.55 g/mol
Molecular Formula C13H7ClFIO
XLogP34.6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass359.92142 g/mol
Monoisotopic Mass359.92142 g/mol
Topological Polar Surface Area17.1 Ų
Heavy Atom Count17
Formal Charge0
Complexity279
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
32384-65-9
Empagliflozin
Established in 1999, Hankang Pharmaceutical Group stands as a prominent CRO-CDMO integrated service enter...
Established in 1999, Hankang Pharmaceutical Group stands as a prominent CRO-CDMO integrated service enterprise in China. Focused on generic drugs while venturing into innovative ones, the group is dedicated to offering comprehensive solutions to the industry. Presently, Hankang has crafted over 200 varieties for 600+ domestic and international companies, serving 10+ innovative drugs. It has successfully developed more than 10 initial generic drugs, with over 20 varieties endorsed by the top three domestic companies and 30 exceeding a 100 million output value.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY